“I wanted to create a convenient and comfortable seat to use when traveling with a piece of luggage,” said an inventor, from Marysville,Wash.,”soIinventedtheSEATCASE.Mydesign ensures a seat is always available, so you never have to sit on the floor.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The invention provides a new seat designed for use atop a piece of luggage. In doing […]

The global Autoimmunity Diagnostics Market, valued at US$5.26 billion in 2024stood at US$5.57 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2031, culminating in a forecasted valuation of US$8.98 billion by the end of the period. The autoimmune disease diagnosis market is consistently growing, fueled by

The Sides Are Chosen, Now It’s Time to Rally the Troops FRANKLIN, NEW JERSEY / ACCESS Newswire / August 7, 2025 / Silver Scott Mines, Inc. (OTC Pink:SILS) today announced that at RivalMEMECoins.com we are one week in and the lines are drawn deeper than a TikTok comment section! Team PeachHim.com and Team EggplantHer.com have

Ocean City, Maryland, Aug. 07, 2025 (GLOBE NEWSWIRE) — Today, Ocean City, Maryland (OCMD) announced a variety of end of summer travel and lodging deals, as well as an inaugural Summer Sendoff event that will occur from August 21-24. The beloved East Coast beach town is providing visitors one last chance to experience the joy

(Copenhagen:GMAB),(LSE:0MGB), Company Announcement COPENHAGEN, Denmark; August 7, 2025 Epcoritamab in combination with rituximab and lenalidomide (R2) demonstrated statistically significant improvement in Overall Response Rate (ORR; 95.7%, p < 0.0001) and Progression-Free Survival (HR 0.21, p-value <0.0001) versus R2 alone in patients with relapsed/refractory (R/R) Follicular Lymphoma (FL) Results from EPCORE FL-1 form the basis of

Genmab Announces Phase 3 EPCORE(R) FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) GlobeNewswire August 07, 2025 Company Announcement COPENHAGEN, Denmark; August 7, 2025 Epcoritamab in combination with rituximab and lenalidomide (R2) demonstrated statistically significant improvement in Overall Response Rate (ORR; 95.7%, p < 0.0001) and Progression-Free Survival

Ocean City, Maryland Bids Farewell to Summer with Travel Deals and Events 'Summer Send Off' programming to celebrate the end of summer with an open-air celebration and lodging discounts, welcoming visitors to book late-August stays GlobeNewswire August 07, 2025 Ocean City, Maryland, Aug. 07, 2025 (GLOBE NEWSWIRE) — Today, Ocean City, Maryland (OCMD) announced a

NEW YORK, NY / ACCESS Newswire / August 7, 2025 / If you suffered a loss on your Lockheed Martin Corporation (NYSE:LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=160278&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / August 7, 2025 / If you suffered a loss on your Flywire Corporation (NASDAQ:FLYW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/flywire-corporation-lawsuit-submission-form?prid=160277&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

It's no secret that pigment is one of the most fickle conditions to treat. With an unpredictable nature influenced by a variety of factors, such as genetics, skin type, hormonal changes, and more, achieving consistent results can seem almost impossible for even the most experienced practitioners.Monarch Aesthetic Services (MAS) is proud to offer the HELIOS